Eric Molloy, MD
Hospitalist · Evanston, ILNPI 1174721070
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Boston Scientific at 26.7% of the total. Among hospitalist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $44.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$507
- Apollo Endosurgery US Inc$323
- Johnson & Johnson$216
- Pfizer$157
- Sanofi$138
- Phathom Pharmaceuticals, Inc.$128
- plus $430 from 11 others
What the payments were for
- Food & beverage$1,899100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $507 |
| Apollo Endosurgery US Inc | 4 | $323 |
| Johnson & Johnson | 6 | $216 |
| Pfizer | 6 | $157 |
| Sanofi | 1 | $138 |
| Phathom Pharmaceuticals, Inc. | 2 | $128 |
| Janssen Scientific Affairs, LLC | 1 | $112 |
| AbbVie(2 entities) | 5 | $78 |
| QOL Medical, LLC | 2 | $63 |
| Ironwood Pharmaceuticals, Inc | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Cook Medical LLC | 1 | $29 |
| Organogenesis Inc. | 1 | $22 |
| Bristol Myers Squibb | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
| CSL Behring | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OverStitch Endoscopic Suturing System$411
- X-Tack Endoscopic HeliX Tacking System$233
- Apollo 2-0 Polypropylene Endobariatric Suture$213
- DUPIXENT$138
- Apollo ESG NXT System$119
- Tremfya$119
- VOQUEZNA$117
- ORBERA Intragastric Balloon System$117
- STELARA$112
- XELJANZ$109
How this compares
$1,899 in reported general payments places this provider in the 95th percentile of 1,328 hospitalist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 24 | $591,265 |
| CreonLipase/Protease/Amylase | 11 | $59,484 |
| LinzessLinaclotide | 46 | $35,205 |
| TrulancePlecanatide | 18 | $11,267 |
| MovantikNaloxegol Oxalate | 17 | $9,967 |
| Ondansetron Hcl | 13 | $7,092 |
| Lubiprostone | 12 | $5,072 |
| Omeprazole | 163 | $2,634 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 126 | $2,619 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 34 | $2,220 |
| Ondansetron OdtOndansetron | 39 | $916 |
| Famotidine | 36 | $806 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 39 | $557 |
| Pantoprazole Sodium | 30 | $434 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $173 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $216 | $591,26524 claims |
| AbbVieCreon, Linzess | $78 | $94,68957 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $32 | $11,26718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,328 hospitalist providers in Illinois.
Other hospitalist in Evanston
- Juan Pablo Salazar AdumEvanston$11K
- Wael GhaliEvanston$5K
- Odulola OdusanyaLibertyville$544K
- Salih SamoChicago$251K
- Eric GluckChicago$80K
- Jorge Gomez AlarconLake Forest$72K
- Alvin ThomasChicago$28K
- Osman QaiyumMount Vernon$22K
- Wajahat HumayunMaywood$20K
- Gabriel DiazMaywood$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.